{"id":12754,"date":"2020-06-22T18:24:00","date_gmt":"2020-06-22T15:24:00","guid":{"rendered":"https:\/\/en.buradabiliyorum.com\/gilead-sciences-to-start-testing-inhaled-version-of-remdesivir\/"},"modified":"2020-06-22T18:24:00","modified_gmt":"2020-06-22T15:24:00","slug":"gilead-sciences-to-start-testing-inhaled-version-of-remdesivir","status":"publish","type":"post","link":"https:\/\/buradabiliyorum.com\/en\/gilead-sciences-to-start-testing-inhaled-version-of-remdesivir\/","title":{"rendered":"#Gilead Sciences to start testing inhaled version of remdesivir"},"content":{"rendered":"

“#Gilead Science<\/a>s to start testing inhaled version of remdesivir<\/strong>”<\/p>\n

\n
\n
\n

June 22, 2020 |<\/span> 11:24am <\/p>\n

\n Join the New York Post and Mansion Global for a live conversation on how COVID-19 has affected top real estate markets in the US, Friday, 6\/26 @ 12 p.m. EST. Register here.<\/p><\/div>\n
\n Gilead Sciences announced plans Monday to start testing an inhaled version of its experimental coronavirus drug to determine whether it could treat the deadly disease sooner.<\/p>\n

The pharma giant will begin screening patients this week for early-stage trials of the breathable form of remdesivir, which has been shown to help COVID-19 patients recover faster, Gilead CEO Daniel O\u2019Day said. The company expects to begin the studies in August.<\/p>\n

While patients currently get doses of remdesivir through IV drips, an inhaled form of the drug could be delivered through a nebulizer, which would make it easier to administer outside of hospitals at earlier stages of infection, O\u2019Day said.<\/p>\n

\u201cFor patients who are at high risk of disease progression, it could be particularly beneficial to start treatment outside the hospital,\u201d O\u2019Day said in an open letter detailing Gilead\u2019s plans. \u201cOur hope is that earlier intervention could help patients avoid hospitalization altogether.\u201d<\/p>\n

California-based Gilead revealed earlier this month that it was working on an inhaled form of remdesivir. The Food and Drug Administration app<\/a>roved the drug for emergency use in May after a government-backed study showed it helped reduce recovery times by four days on average.<\/p>\n

Gilead has so far studied the drug only in hospitalized patients but now wants to explore its potential benefits outside of hospitals, according to O\u2019Day. The company plans to conduct trials of the intravenous form in \u201coutpatient settings\u201d such as infusion centers and nursing homes, he said.<\/p>\n

The next wave of research will also examine the use of remdesivir in children and in combination with two other drugs known as \u201cimmune modulators,\u201d O\u2019Day added. Gilead expects to manufacture more than 2 million treatment courses of the drug by the end of this year and \u201cmany millions more by 2021,\u201d he said.<\/p>\n

\u201cOur best hope of beating COVID-19 is with a set of tools at our disposal: complementary therapeutics, effective vaccines and widespread testing,\u201d O\u2019Day said. \u201cHaving already seen that science can deliver answers, we can be hopeful of continued progress.\u201d<\/p>\n

Gilead shares tumbled as much as 3.1 percent to $75.04 despite the news<\/a> on Monday. The stock ended last week up more than 19 percent for the year as Gilead emerged as one of the leaders in the pharmaceutical industry\u2019s battle against the coronavirus pandemic.\n <\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n

Source<\/a><\/span><\/p>\n

\n

If you want to read more Business News articles, you can visit our General category.<\/a><\/span><\/strong><\/p>\n<\/blockquote>\n

\n

if you want to watch Movies<\/a> or Tv Shows go to Dizi.BuradaBiliyorum.Com<\/a> <\/span> for forums sites go to Forum.BuradaBiliyorum.Com<\/a><\/span><\/strong><\/p>\n<\/blockquote>\n","protected":false},"excerpt":{"rendered":"

“#Gilead Sciences to start testing inhaled version of remdesivir” June 22, 2020 | 11:24am Join the New York Post and Mansion Global for a live conversation on how COVID-19 has affected top real estate markets in the US, Friday, 6\/26 @ 12 p.m. EST. Register here. Gilead Sciences announced plans Monday to start testing an…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"","fifu_image_alt":"","footnotes":""},"categories":[1],"tags":[25702],"class_list":["post-12754","post","type-post","status-publish","format-standard","hentry","category-general","tag-gilead-sciences-to-start-testing-inhaled-version-of-remdesivir"],"_links":{"self":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/12754","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/comments?post=12754"}],"version-history":[{"count":0,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/12754\/revisions"}],"wp:attachment":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media?parent=12754"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/categories?post=12754"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/tags?post=12754"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}